The board of directors of Zylox-Tonbridge Medical Technology Co., Ltd. announces that with effect from September 5, 2022, the address of the principal place of business of the Company in Hong Kong is changed to 5/F, Manulife Place, 348 Kwun Tong Road, Kowloon, Hong Kong.
Zylox-Tonbridge Medical Technology Co., Ltd.
Equities
2190
CNE100004JD2
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.34 HKD | +0.98% | +9.07% | -16.88% |
Mar. 22 | Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023 | MT |
Mar. 21 | Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.88% | 428M | |
+12.64% | 128B | |
-9.04% | 10.51B | |
+0.91% | 8.71B | |
+16.58% | 7B | |
+25.50% | 5.02B | |
+7.20% | 3.39B | |
-1.07% | 3.02B | |
-8.73% | 2.07B | |
-10.15% | 2.06B |
- Stock Market
- Equities
- 2190 Stock
- News Zylox-Tonbridge Medical Technology Co., Ltd.
- Zylox-Tonbridge Medical Technology Co., Ltd. Announces Change of Principal Place of Business in Hong Kong